Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rofecoxib vs Placebo and Diclofenac in Acute Painful Rotator Cuff Syndrome
NCT00140933Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rofecoxib in rotator cuff syndrome (RCS), sponsored by Merck & Co.. Started Apr 2003; status: terminated.
02
Drugs
rofecoxib
03
Conditions
rotator cuff syndrome (RCS)
Beyond the preview
Go deeper on NCT00140933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140933.